First Time User? Enroll now.
Get Care Now
Home > Recent Numbered Memos
Significant changes pertaining to test performance or availability, or to administrative functions within the McLendon Clinical Laboratories and the Department of Pathology and Laboratory Medicine are announced via departmental Numbered Memos which are distributed throughout the Hospitals and Health Care System.
These memos will also be made available at this site in Portable Document Format (.pdf files).
Changes to CSF Oligoclonal Banding Order
Lyme Disease Antibody Testing
Spotted Fever Group Rickettsia and Ehrlichia Antibody Testing
Molecular Genetics Preliminary Verification in Epic by PhD faculty
Age-Specific Prostate Specific Antigen Reference Ranges and Prostate Cancer Screening Agile Pathway
New ImmunoCAP Allergy Panel
Testing Resumed - SPINIAL MUSCULAR ATROPHY (SMN 1/2) DNA ASSAY [LAB11165A]
Rapid testing on Positive Blood Cultures for Gram-Positive Organisms
Changes to Cystic Fibrosis (CF) Carrier Screening and Diagnostic Testing
Update to everolimus reference interval
Discontinuation of random "spot" urine monoclonal gammopathy testing
Test Obsolete: Metanephrines, Fractionated, Random Urine, Mayo
Toxoplasma IgM and IgG antibody testing
Testing Resumes: Natural Killer (NK) Cell Function
Test Down-SPINAL MUSCULAR ATROPHY (SMN 1/2) DNA ASSAY (LAB11165A)
ANA and ANCA IFA Testing
Rapid Testing on Positive Blood Cultures for Yeast
Anti-Cardiolipin and Anti-Beta2 Glycoprotein 1 Antibodies Testing Methodology Change
New Test: KIT p.D816V Mutation analysis
Standardization of Ferritin Reference range and Iron Deficiency Agile Pathway
Temporary unavailability of the NK Cell Function Assay provided by Cincinnati Children's CBCI Clinical Laboratories
Immunology Laboratory IFA Testing
Temporary suspension of TPO Antibody Testing
Gastrointestinal Pathogen Panel Collection Update: Fecal Swab Transport System
Change in Directorship of Cytogenetics Laboratory
Laboratory Diagnosis of C. difficile Infection-CHANGES IN TESTING
Muscle Biopsy Submission Procedure
Updated formulation of TSH reagent with modified lower limit
Change in Directorship of Quality Management Services
Change in Add-On Testing for Pathology orders
Interruption in Serum and Urine Protein Electrophoresis and Immunofixation
Change in Antimicrobial Susceptibility Testing Methodology for Staphylococcus and Enterococcus spp.
BRAF Somatic Mutation Testing-Hematologic Malignancies
New Measles PCR test
Changes to Serum Free Light Chain Testing
ANA Testing In-house
Update to PCR test for Methicillin Resistant Staphylococcus aureus (MRSA) screening
For listings of McLendon Clinical Laboratories & Department of Pathology and Laboratory Medicine numbered memos see Numbered Memo Archive. For Numbered Memos prior to January 1, 2008 - contact McLendon Clinical Laboratories Administration Office
UNC HospitalsMcLendon Clinical Laboratories101 Manning DriveChapel Hill, NC 27514
